FINANCIAL PERFORMANCE ANALYSIS ON ACI PHARMACEUTICALS Ltd

Abstract

Bangladesh is a country with a lot of potentiality. Pharmaceutical sector in our country is one of them. Local companies dominate this sector and the sector is developing day by day. In the project report I have discussed about the overall pharmaceutical industry in Bangladesh and financial performance of top companies. Financial performance of ACI is the main concern of my topic. Though ACI is one of the top pharmaceutical companies in Bangladesh, but it has many areas to improve. The ratio analysis of ACI shows that the company’s financial performance is low compared to the industry average. In this competitive market ACI should focus on some important issues like cost reduction, asset utilization, product and service quality etc. Wealth maximization should be the ultimate goal of ACI. Currently the market size of pharmaceutical industry in Bangladesh worth’s US$ 1.1 billion and by 2020 the size is estimated to be UD$ 2.30 billion. Bangladesh is a market of generic medicines and 460 generic medicines are registered in our country. Top organizations have own R&D to produce new products. Besides heading towards the self-sufficiency meeting 98% of local demand, the pharmaceutical industry is exporting medicine to other countries. ACI has many strengths and opportunities with experienced and skilled top management.If they can utilize the assets in a proper way, they can earn more profit and can contribute more in the economy of Bangladesh.